Medflow Plus
7 The Mill
Stane Street
Chichester
West Sussex
PO18 0FF
The Hughes Group originally started in 2001 as a private family office. Healthcare operations began in 2015 in neurology and in 2018 expanded into drug development and medical devices. These included robotic medical devices for drug infusion in neuro oncology, modifying existing large molecule drugs into water soluble versions for infusion via catheters into the brainstem and diagnostic assays for viral antibodies and antigens.
Read More
They have engineered a mass human dual testing protocol to control and eradicate COVID-19. They have clinical trials from the UK, USA, Sweden and China which show a combined accuracy of 98.8% (96.8% diagnostic sensitivity and 97.1% specificity) for their rapid test kits which are fully home use approved in the UK and EU, having received validation from Public Health England Porton Down.
The Hughes COVID-19 lateral flow test kits are used and trusted by companies around the world including all UK airports and the NHS. They are available in single packaging or in boxes of 25 to meet your requirements.
The test very simple to administer. Differing from your usual nasopharyngeal lateral flow COVID-19 test as the test only needs to enter the lower nostril therefore, reducing discomfort without compromising on accuracy. The test only requires a 1-2cm swab unlike the standard 9-10cm swab into the nostril
This test is backed by the NHS and plans are underway for a UK manufacturing facility in Northern Ireland.
Hughes Healthcare Products
No products found which match your selection.
